RCT- LMA Supreme™ Versus the Spritztube® Tracheal Cannula in Anesthetized Adult Patients
A Prospective Randomised Controlled Trial of the LMA Supreme™ Versus the Spritztube® Tracheal Cannula in Anesthetized Adult Patients
1 other identifier
interventional
355
0 countries
N/A
Brief Summary
The study compares the LMA Supreme™ versus the Spritztube® tracheal cannula in anesthetized adult patients. The current randomized study is designed to assess the success placement of blind insertion using LMA Supreme™ , in comparison with the Spritztube® tracheal cannula. In addition, time, number of attempts, easy insertion and the number of complications at insertion and removal will be assessed. The investigators hypothesize that the LMA Supreme™ versus the Spritztube® tracheal cannula will similarly perform during anesthetized adult patients despite differences in their structural design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 20, 2017
CompletedFirst Submitted
Initial submission to the registry
February 12, 2018
CompletedFirst Posted
Study publicly available on registry
February 23, 2018
CompletedFebruary 23, 2018
February 1, 2018
10 months
February 12, 2018
February 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the successful placement of device in two groups
A successful intubation attempt was recognized if the breathing circuit was connected, the breath sounds over the lung were present and the End tidal CO2 trace was revealed.
Intraoperative
Secondary Outcomes (5)
Insertion time (in seconds)
Intraoperative
Number of attempts
Intraoperative
Easy to insert
Intraoperative
number of complications at insertion
Intraoperative
number of complications at removal
Postoperative
Study Arms (2)
Spritztube®
EXPERIMENTALThe patients were randomly allocated to two groups by using computer-generated numbers.In Spritztube® group, Spritztube® was inserted into each patient after anesthesia induction.
LMA Supreme™
ACTIVE COMPARATORThe patients were randomly allocated to two groups by using computer-generated numbers.In vgroup, LMA Supreme™was inserted into each patient after anesthesia induction.
Interventions
After preoxygenation, anaesthesia was induced with midazolam, propofol, and fentanyl,Spritztube® was inserted and both cuffs inflated
After preoxygenation, anaesthesia was induced with midazolam, propofol, and fentanyl,LMA Supreme™ was inserted and both cuffs inflated
Eligibility Criteria
You may qualify if:
- American Society of Anaesthesiologists (ASA) physical status classification I, II, and III;
- Age \> 18 years
- Elective surgery in the supine position
You may not qualify if:
- Pregnancy
- Age \<18 years
- Not eligibility for surgery
- Predicted difficult airway management
- Positive history for esophageal or pharyngeal diseases
- Emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
De Rosa S, Messina A, Sorbello M, Rigobello A, Colombo D, Piccolo A, Bonaldi E, Gennaro P, Urukalo V, Pellizzari A, Bonato R, Carboni SC. Laryngeal Mask Airway Supreme vs. the Spritztube tracheal cannula in anaesthetised adult patients: A randomised controlled trial. Eur J Anaesthesiol. 2019 Dec;36(12):955-962. doi: 10.1097/EJA.0000000000001106.
PMID: 31644512DERIVED
Study Officials
- STUDY DIRECTOR
Raffaele Bonato, MD
Department of Anesthesiology and Intensive Care, San Bortolo Hospital, Vicenza, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- opening a sealed envelope, provided by an independent physician blinded to patient's allocation In addition, outcome assessor were blinded
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
February 12, 2018
First Posted
February 23, 2018
Study Start
September 15, 2016
Primary Completion
July 10, 2017
Study Completion
October 20, 2017
Last Updated
February 23, 2018
Record last verified: 2018-02